Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity
Open Access
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 9 (4) , 257-265
- https://doi.org/10.1053/bbmt.2003.50009
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients After Nonmyeloablative ConditioningJournal of Clinical Oncology, 2002
- Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimenBlood, 2002
- Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effectBone Marrow Transplantation, 2001
- Allogeneic hematopoietic cell transplantation for multiple myelomaSeminars in Hematology, 2001
- High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsBlood, 2001
- Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantationLeukemia, 2001
- Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centresBritish Journal of Haematology, 2001
- Donor leukocyte infusions for multiple myelomaBone Marrow Transplantation, 2000
- In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationBlood, 2000
- Progress in haematopoietic stem cell transplantation for multiple myelomaJournal of Internal Medicine, 2000